FDA Broad Agency Announcement (BAA) — Advancing Regulatory Science
Supports Extramural research contracts advancing FDA's regulatory science priorities modernizing product evaluation, post market surveillance, and public health preparedness.
About
The FDA Broad Agency Announcement for Advancing Regulatory Science sits under the Office of Regulatory and Emerging Science and funds extramural research and development work tied to FDA priorities. Unlike a grant program, this route uses federal contracts, so applicants need to be comfortable bidding into a procurement-style process rather than a standard research-award competition.
The announce…
AIBiotechAdvanced MaterialsMedtech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.